Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$1.33 - $2.35 $2,691 - $4,756
-2,024 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$1.86 - $3.24 $1.55 Million - $2.7 Million
-832,142 Reduced 99.76%
2,024 $4,000
Q4 2021

Jan 28, 2022

BUY
$2.2 - $4.01 $152,438 - $277,852
69,290 Added 9.06%
834,166 $1.97 Million
Q3 2021

Nov 12, 2021

BUY
$3.34 - $4.63 $2.55 Million - $3.54 Million
764,876 New
764,876 $2.56 Million
Q4 2019

Jan 31, 2020

SELL
$2.72 - $3.15 $354,872 - $410,974
-130,468 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$2.58 - $3.97 $88,677 - $136,452
34,371 Added 35.77%
130,468 $417,000
Q2 2019

Jul 30, 2019

BUY
$3.0 - $5.5 $288,291 - $528,533
96,097 New
96,097 $325,000

About MediWound Ltd.


  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $690M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.